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Accepted 11 August 2012AbstractObjective: Coexistence of Klinefelter syndrome and holoprosencephaly (HPE) is rare. We report alobar HPE, cebocephaly, and micropenis in
a Klinefelter fetus of a mother with type 2 diabetes mellitus with obesity and poor metabolic control.
Case Report: A 38-year-old woman was referred for therapy of type 2 diabetes mellitus with poor glycemic control at 24 weeks of gestation. On
examination, she had a body height of 162 cm and a body weight of 105 kg. She had been treated with oral medication for diabetes mellitus for 4
years with poor maternal metabolic control. She had prominent glucosuria and glycemia. Her hemoglobin A1c was 7.5% (normal range:
3.4e6.1%), and the fasting glucose level was 141 mg/mL (normal range: 70e99 mg/mL) during this visit. Her husband was 46 years old.
Prenatal ultrasound revealed a singleton fetus with fetal biometry equivalent to 24 weeks, alobar HPE, cebocephaly, and micropenis. As a result
of poor maternal heath and fetal anomaly, the parents elected to terminate the pregnancy, and a 986-g male fetus was delivered with hypo-
telorism, HPE, cebocephaly, micropenis, and cryptorchidism. Cytogenetic analysis of the cord blood revealed a karyotype of 47,XXY. The
parental karyotypes were normal. Polymorphic DNA analysis revealed a paternal origin of the extra X chromosome. Molecular analysis of the
HPE genes of SHH, ZIC2, SIX3, and TGIF revealed no mutations.
Conclusion: Prenatal diagnosis of HPE should include a biochemical examination to identify metabolic factors such as maternal diabetes, and
preventive management should be considered in subsequent pregnancies to achieve good control of maternal diabetes.
Copyright  2012, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Klinefelter syndrome, or 47,XXY, is characterized by
hypogenitalism and hypogonadism, with or without long legs,
dull mentality, and/or behavioral problems, and is one of the
most common causes of hypogonadism and male infertility,
affecting 1 in 500 males [1]. Holoprosencephaly (HPE) iscs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Prenatal ultrasound at 24 weeks of gestation shows (A) alobar holoprosencephaly with a fused thalamus and a single ventricle; (B) a prominent nose (arrow);
(C) micropenis (arrow); and (D) cebocephaly and hypotelorism on three-dimensional ultrasound.
Fig. 2. The fetus at birth with (A) hypotelorism and cebocephaly; (B) a single nostril; and (C) micropenis and cryptorchidism.
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midline cleavage of the embryonic forebrain and comprises
variable phenotypes including alobar HPE, semilobar HPE,
lobar HPE, midline interhemispheric fusion variant, and
microform, and affects one in 10,000 live births and four in
1000 conceptuses [2e6]. HPE can be caused by chromosomal
abnormalities, microdeletions, or mutations in the HPE genes,
genetic syndromes, and nongenetic risk factors such as
maternal illness, therapeutic and nontherapeutic exposures,
nutritional factors, sociodemographic factors and teratogens of
maternal diabetes, hypocholesterolemia, alcohol, and retinoic
acid [7e13]. Coexistence of Klinefelter syndrome and HPE is
very rare. Here, we report the perinatal findings of alobar HPE,
cebocephaly, and micropenis in a Klinefelter fetus of a mother
with type 2 diabetes mellitus with obesity and poor metabolic
control.
Case report
A 38-year-old, gravida 2, para 1 woman was referred for
therapy of type 2 diabetes mellitus with poor glycemic control
at 24 weeks of gestation. On examination, she had a body
height of 162 cm and a body weight of 105 kg. She had been
treated with oral medication for diabetes mellitus for 4 years,
with poor maternal metabolic control. She had prominentFig. 3. A karyotypglucosuria and glycemia. Her hemoglobin A1c was 7.5%
(normal range: 3.4e6.1%), and fasting glucose level was
141 mg/mL (normal range: 70e99 mg/mL) during this visit.
Her husband was 46 years old. The couple had a 1-year-old
healthy son, and there was no family history of congenital
malformations. Prenatal ultrasound revealed a singleton fetus
with fetal biometry equivalent to 24 weeks, alobar HPE,
cebocephaly, and micropenis (Fig. 1). The internal organs,
limbs, and digits were normal. As a result of poor maternal
heath and fetal anomaly, the parents elected to terminate the
pregnancy, and a 986-g male fetus was delivered with hypo-
telorism, HPE, cebocephaly, micropenis, and cryptorchidism
(Fig. 2). Cytogenetic analysis of the cord blood revealed
a karyotype of 47,XXY (Fig. 3). The parental karyotypes were
normal. Polymorphic DNA analysis revealed a paternal origin
of the extra X chromosome (Fig. 4). Molecular analysis of the
HPE genes of SHH, ZIC2, SIX3, and TGIF revealed no
mutations.
Discussion
The present case represents a rare coexistence of two
malformations: HPE and Klinefelter syndrome. To the best
of our knowledge, only three cases with concomitant HPE
and Klinefelter syndrome have been reported [14e16].e of 47,XXY.
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a dysmorphic face, a nose with a single orifice, alobar HPE,
and a karyotype of 47,XXY,18pe. The phenotype of HPE is
likely to be caused by a deletion of 18p and haploinsufficiency
of the TGIF gene. Armbruster-Moraes et al [15] reported first-
trimester ultrasound diagnosis of premaxillary agenesis and
HPE in a 27-year-old pregnant woman, and chorionic villus
sampling revealed a karyotype of 47,XXY. Chen et al [16]
reported a 2-day-old neonate with lissencephaly, HPE,
microcephaly, hypotelorism, an upturned nose, cleft palate,
Aicardi syndrome, and a karyotype of 47,XXY.
Studies on the extra X chromosome in Klinefelter
syndrome have shown a frequency of 50% maternal origin and
50% paternal origin [17]. The present case was associated with
advanced parental age and a paternal origin of aneuploidy.
Klinefelter syndrome is known to be associated with double
aneuploidy [18]. Major chromosomal abnormalities associated
with HPE include trisomy 13, triploidy, trisomy 18, del(2p),
del(2q), dup(3p), del(13q), del(18p), del(21q), and interstitial
deletion of 14q13 [19]. 47,XXY is not a frequent aneuploidy
associated with HPE, and HPE is not a characteristic feature of
47,XXY. The present case had characteristic Klinefelter
syndrome features of hypogenitalia and hypogonadism, and
manifested micropenis on prenatal ultrasound. Cytogenetic
abnormalities have been reported in 32e41% of HPE patients,Fig. 4. Representative electrophoretograms of quantitative fluorescent polymerase ch
The markers DXS6791 (Xq25) and DXS6806 (Xq27.3) show two different parenta
with 47,XXY.with trisomy 13 most common in up to 75%, triploidy in up to
20%, and trisomy 18 in up to 1e2% of the HPE cases with
aneuploidies [13]. The present case was not associated with
double aneuploidy, and there were no phenotypic features of
trisomy 13, triploidy, or trisomy 18.
To date, at least 13 HPE loci and nine HPE genes have been
identified [12]. About 22% of patients with HPE and normal
karyotypes have mutations or microdeletions in one of the four
most common HPE genes: SHH (OMIM 600725) at 7q36.3;
ZIC2 (OMIM 603073) at 13q32.3; SIX3 (OMIM 603714) at
2p21; and TGIF (OMIM 602630) at 18p11.31 [12]. Other less
frequent HPE genes include: PTCH1 at 9q22.32 (OMIM
601309); GLI2 (OMIM 165230) at 2q14.2; DISP1 (OMIM
607502) at 1q41; NODAL (OMIM 601265) at 10q22.1; FOXH1
(OMIM 603621) at 8q24.3; and TDGF1 (OMIM 187395) at
3p21.31 [12]. The present case did not have mutations in the
common HPE genes of SHH, ZIC2, SIX3, and TGIF.
The peculiar aspect of the present case was the association
of HPE with elevated levels of maternal fasting glucose and
glycosylated hemoglobin, and provides an example of major
congenital anomalies during pregnancy in a mother with type
2 diabetes mellitus with obesity and poor metabolic control.
Maternal diabetes is a well-recognized risk factor for HPE
[20e22]. HPE is estimated to occur in 1e2% of births to
diabetic mothers, indicating a 100e200-fold risk for HPE asain reaction assays at short tandem repeat markers specific for chromosome X.
l X alleles, indicating a paternal origin of the extra X chromosome in this case
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found in 6e9% of mothers of children with HPE [25,26]. In
addition to HPE, diabetic embryopathy includes other struc-
tural abnormalities such as anencephaly, spina bifida, micro-
cephaly, caudal regression syndrome, sacral agenesis, limb
defects, renal agenesis, hydronephrosis, ureteric abnormalities,
transposition of the great vessels, ventricular septal defect,
atrial septal defect, coarctation of the aorta, cardiomyopathy,
single umbilical artery, duodenal atresia, anorectal atresia, and
small left colon syndrome [27]. Maternal diabetes has toxic
effects on the embryos, and maternal obesity and diabetes are
associated with an increased risk for central nervous system
birth defects [28e31]. Prenatal diagnosis of HPE should
include a biochemical examination to identify metabolic
factors such as maternal diabetes, and preventive management
should be considered in subsequent pregnancies to achieve
good control of maternal diabetes.
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